PlainRecalls
FDA Drug Moderate Class II Completed

Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.

Reported: October 2, 2024 Initiated: August 30, 2024 #D-0660-2024

Product Description

Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.

Reason for Recall

Subpotent Drug

Details

Units Affected
2,031,480 ointments
Distribution
Product was distributed nationwide within the United States.
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: 2,031,480 ointments.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on October 2, 2024. Severity: Moderate. Recall number: D-0660-2024.